• Breath Testing Shows Promise as Reliable, Simple Method for Diagnosing FA, Other Diseases
  • ‘Rare Impact Awards’ Dinner Marks Orphan Drug Act and NORD at 35
  • #ECRD2018 – EU Must Do More for Rare Disease Patients, Eurordis Leaders Say
  • MDA Awards $2.6 Million in Grants to Improve Understanding of Neuromuscular Diseases
  • Clinical Management of Adult Siblings with FA Described in Case Report
  • Methylene Blue Analogues Improved Mitochondrial Function and Increased Frataxin Levels in Cell Study
  • #ECRD2018 – Patient Access and Collaboration Focus of Eurordis Meeting May 10-12
  • UK Pilot Study to Evaluate Effects of Stem Cell Therapy in Friedreich’s Ataxia Patients
  • FA Patients Show Gradual Worsening of Certain Auditory Responses, Study Says
  • Retrotope Submits Design of Pivotal Trial for Its Friedreich’s Ataxia Therapy to FDA
  • #AAN2018 – FA Patients Show Gradual Decline in Visual Acuity Over Time, Study Finds
  • Moving Out Despite Friedreich’s Ataxia